Targeting Inflammation in Cancer-Related-Fatigue: A Rationale for Mistletoe Therapy as Supportive Care in Colorectal Cancer Patients.

Conclusion. The clinically used mistletoe medication (Iscador®Qu) is the first candidate to be included in a supportive care modus into chemo- or chemo-radiotherapy protocols for colorectal patients to improve CRF without discernable toxicities. PMID: 24766319 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24766319?dopt=Abstract

Source: Inflammation and Allergy Drug Targets - April 27, 2014 Category: Allergy & Immunology Authors: Bock PR, Hanisch J, Matthes H, Zanker KS Tags: Inflamm Allergy Drug Targets Source Type: research